Introduction {#S1}
============

Embryonic stem cells (ESCs) have the unique ability to differentiate into all somatic cell types^[@R1]^. This developmental plasticity is conferred by the pluripotent gene expression program, which is maintained through a combination of ESC specific transcription factors and recently characterized epigenetic regulators^[@R2]--[@R4]^. Polycomb group proteins are important epigenetic regulators that repress the expression of key developmental regulators in ESCs, thus stabilizing the pluripotent gene expression program^[@R3],[@R5],[@R6]^. Two major Polycomb repressive complexes (PRCs), designated as PRC1 and PRC2, have been described. PRC2 mediates di- and trimethylation of histone H3 lysine 27 (H3K27me2/3)^[@R7]--[@R10]^, while PRC1 subunits Ring1A/B catalyze ubiquitination of histone H2A lysine 119 (ubH2A)^[@R11],[@R12]^. Interestingly, some genes enriched for H3K27me2/3 are also enriched for H3K4me3, a mark generally found at actively transcribed genes^[@R13]^. These bivalent modifications are found principally at key developmental regulators and may help repress these genes in ESCs while enabling their rapid induction in response to developmental signals^[@R14]^. Recent investigations reveal that PRC1-mediated ubH2A also marks bivalent genes and regulates their expression in ESCs^[@R15]--[@R17]^. Simultaneous depletion of Ring1A and Ring1B in ESCs causes de-repression of bivalent genes and loss of ESC identity^[@R16],[@R18]^. Therefore, PRC1 binding and, possibly, PRC1-mediated H2A ubiquitination, may be required for the efficient repression of key developmental related genes in ESCs. Interestingly, recent studies reveal that ubH2A is enriched at promoters of genes involved in metabolism and other processes, suggesting additional roles for Ring1B and ubH2A in ESCs^[@R19]^. Reinforcing the links between Ring1B, ubH2A, and transcriptional silencing, genes bound by PRC1 and enriched for ubH2A in ESCs are associated with RNAPII-S5P, which does not produce mature mRNA^[@R19]^. This is consistent with a role for ubH2A in transcriptional repression^[@R18]--[@R21]^. However, non-enzymatic PRC1 function may also contribute to gene repression by directly compacting chromatin, blocking remodeling, inhibiting transcription initiation, and repressing gene expression^[@R22]--[@R25]^. Unambiguously demonstrating the functions of ubH2A in PRC1-mediated gene repression *in vivo* remains a challenge in higher eukaryotes.

Like other histone modifications, ubH2A is a reversible mark that is removed through the activity of deubiquitinating enzymes. The levels of cellular ubH2A are determined by the balance between PRC1-mediated ubH2A and ubH2A deubiquitination. A number of ubH2A deubiquitinases have been reported, including USP16 (Ubp-M), 2A-DUB (MYSM1), USP21, USP7, USP3, and Drosophila *calypso*^[@R26]--[@R30]^. Interestingly, USP16, which is located on human chromosome 21 and triplicated in Down's syndrome, reduces the self-renewal of hematopoietic stem cells and the expansion of mammary epithelial cells, neural progenitors and fibroblasts in mice, suggesting that Usp16 may antagonize PRC1 function in the self-renewal and/or senescence pathways^[@R31]^. Usp16 has also been shown to coordinate with Aurora B-mediated H3S28 phosphorylation to facilitate transcription in quiescent lymphocytes^[@R32]^. However, the specific enzyme that reverses PRC1-mediated H2A ubiquitination in ESCs to regulate ubH2A levels is not known.

During ESC differentiation, bivalent histone modifications are resolved to monovalent modifications^[@R14]^ and pluripotency-specific genes are epigenetically silenced^[@R33],[@R34]^. However, the mechanisms by which repressive H3K27me and ubH2A marks are resolved remains largely unknown. Two JmjC-domain-containing proteins, UTX and JMJD3, can actively remove H3K27me and, therefore, may counteract PRC2-mediated gene silencing during ESC differentiation^[@R35],[@R36]^. Although, there are several known histone H2A deubiquitinases, none have yet been linked to ESC differentiation^[@R26]--[@R30]^. Whether ubH2A deubiquitination is important during ESC differentiation and which enzyme mediates ubH2A deubiquitination during cell fate transitions is not known.

In this study, we report that Usp16 regulates H2A deubiquitination and gene expression in mouse ESCs and during ESC differentiation. Although Usp16^−/−^ ESCs are viable and exhibit normal morphology, gene expression and ubH2A profiles are altered. We further demonstrate that Usp16-mediated ubH2A deubiquitination is essential for ESC differentiation. Usp16^−/−^ ESCs fail to activate lineage-specific gene expression and undergo lineage commitment due to the inability of these cells to remove the repressive ubH2A mark at key developmental regulators. Finally, we demonstrate that Usp16, but not the enzymatically inactive mutant, rescues the differentiation defects of Usp16^−/−^ ESCs. Therefore, this study demonstrates that Usp16 regulates H2A deubiquitination and gene expression in ESCs and Usp16-mediated H2A deubiquitination plays critical roles during ESC differentiation.

Results {#S2}
=======

Usp16 knockout is early embryonic lethal in mice {#S3}
------------------------------------------------

USP16 was first identified as a histone H2A-specific deubiquitinase which regulates cell cycle progression and gene expression in human cells^[@R26]^. To determine whether Usp16 is essential for mammalian development, we knocked out the gene in murine ESCs and produced mice. The targeting vector was designed to replace exons 5 and 6 of mouse Usp16 with a PGK-Neo/Kan cassette ([Fig. 1a](#F1){ref-type="fig"}). Cysteine 205 in exon 6 is required for Usp16 deubiquitinase activity ([Fig. 1a](#F1){ref-type="fig"}). The targeting vector was electroporated into the F1 hybrid (B6/129) ESC line V6.5 and G418 resistant colonies were selected ([Fig. 1a](#F1){ref-type="fig"}). After removing the PGK-Neo/Kan cassette by transient expression of Cre-recombinase, correctly targeted ESCs) were identified by PCR-mediated genotyping ([Fig. 1b](#F1){ref-type="fig"}) and injected into blastocysts to produce mice. After germline transmission, mice heterozygous for Usp16 deletion (Usp16^+/−^) were inbred to obtain Usp16 knockout mice (Usp16^−/−^). However, no homozygous Usp16 knockout mice were obtained ([Fig. 1c](#F1){ref-type="fig"}, 89 mice, 12 litters), indicating that Usp16 deletion is embryonic lethal.

To determine the stage at which Usp16 deletion is lethal, Usp16^+/−^ male and female mice were mated and embryos were isolated. No Usp16^−/−^ embryos were detected at embryonic day (E) 13.5 or E10.5. However, Usp16^−/−^ embryos were detected at E7.5. The majority of E7.5 embryos displayed normal morphology, with closed neural tubes ([Fig. 1d](#F1){ref-type="fig"}). In contrast, a small number of embryos appeared to be partially re-absorbed ([Fig. 1d](#F1){ref-type="fig"}). Morphologically normal embryos were either Usp16^+/+^ or Usp16^+/−^ while the partially re-absorbed embryos were Usp16^−/−^ ([Fig. 1d](#F1){ref-type="fig"}). These results indicate that defects in Usp16^−/−^ embryos occurred prior to E7.5. To determine whether Usp16 deletion affects embryo viability before or after implantation, we collected blastocysts at E3.5. Genotyping analysis of 33 blastocysts recovered from 5 female mice identified 6 Usp16*^−/−^* embryos ([Fig. 1e](#F1){ref-type="fig"}). This result indicates that Usp16 knockout causes lethal developmental defects after implantation but before the E7.5 developmental stage.

Usp16 knockout does not affect ESC viability and identity {#S4}
---------------------------------------------------------

Similar to Usp16 deletion, knockout of any of the PRC subunits in mice, such as Suz12, Ezh2, Eed, or Ring1B , results in early embryonic lethality^[@R37]--[@R40]^. ESCs deficient for these PRC subunits are viable, but are prone to spontaneously differentiate during culture. Therefore, we reasoned that Usp16 knockout ESCs should also be viable. To study the role of Usp16 in early mouse embryonic development, we first derived Usp16^−/−^ ESCs by culturing blastocysts in 2i medium. Surprisingly, of 45 ESC lines derived by this method, 17 were Usp16^+/+^, 28 were Usp16^+/−^ , and none were Usp16^−/−^. The successful generation of multiple Usp16^+/+^ and Usp16^+/−^ ESC lines suggests that our inability to generate Usp16^−/−^ ESC lines was not due to technical reasons. One possible explanation is that Usp16 is required for gene expression reprogramming during the blastocyst to ESCs transition. To test this hypothesis, we derived Usp16^−/−^ ESCs by targeting the remaining wild-type allele in the Usp16^+/−^ ESCs, which were used to generate Usp16 knockout mice. For this purpose, we constructed a conditional targeting vector by inserting a LoxP site upstream of exon 5 and a PGK-Neo/Kan cassette (which was flanked with two FRT sites and one downstream LoxP site) downstream of Usp16 exon 6 ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). This vector was then electroporated into the Usp16^+/−^ ESCs to replace the remaining wild-type Usp16 allele. Since the homologous regions of the conditional targeting vector have been deleted in the Usp16 knockout allele, the wild-type allele should be specifically replaced. ESCs in which the remaining wild-type allele was replaced were selected by G418 resistance. The PGK-Neo/Kan cassette was then removed by transient expression of Flippase and used for the generation of Usp16 conditional knockout mice ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"} see below). Usp16 was deleted from these ESCs by transient expression of Cre recombinase ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). Usp16^−/−^ ESCs were identified by PCR-mediated genotyping ([Supplementary Fig. 1c](#SD1){ref-type="supplementary-material"}) and confirmed by western blot and real-time PCR analysis ([Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}; [Supplementary Fig. 1e](#SD1){ref-type="supplementary-material"}). Usp16^−/−^ ESCs exhibited normal morphology ([Supplementary Fig. 1b](#SD1){ref-type="supplementary-material"}) and expressed pluripotent genes at levels similar to control V6.5 ESCs ([Supplementary Fig. 1e](#SD1){ref-type="supplementary-material"}). Therefore, even though direct derivation of Usp16^−/−^ ESCs from blastocysts could not be achieved, Usp16 does not appear to be required for ESC viability.

Since Usp16^−/−^ ESCs generated by the above described approach have been subjected to multiple rounds of electroporation, which might alter cellular functions, we also derived Usp16^−/−^ ESCs by an alternative approach. We took advantage of Usp16 conditional knockout mice, which were generated by injecting Usp16^2Lox^ ESCs ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}) into blastocysts (data not published). These conditional Usp16 knockout (Usp16^2lox/2lox^) mice were crossed with the inducible Cre expression mouse line, CAGG-Cre, to obtain Usp16^2lox/+^: CAGG-Cre mice. These mice were then interbred or bred with Usp16^2lox/2lox^ mice. ESCs were derived from the offspring of these crossings and Usp16^2lox/2lox^: CAGG-Cre ESCs were identified by PCR mediated genotyping and confirmed by sequencing ([Fig. 2a](#F2){ref-type="fig"}). Usp16 was deleted by culturing Usp16^2lox/2lox^:CAGG-Cre ESCs with 1μM 4-hydroxytamoxifen (4-OHT), which induces nuclear localization of the Cre recombinase, for 3--5 days ([Fig. 2a](#F2){ref-type="fig"}) before switching to 4-OHT free medium. The efficiency of Usp16 deletion was confirmed by western blot assay ([Fig. 2c](#F2){ref-type="fig"}). Consistent with our previous studies, Usp16 knockout caused a specific increase of ubH2A levels, but had no effect on ubH2B levels ([Fig. 2c](#F2){ref-type="fig"}, the intensity of ubH2A signal were quantified and labeled). Usp16^−/−^ ESCs exhibited normal morphology ([Fig. 2b](#F2){ref-type="fig"}) and have growth rates ([Fig. 2e](#F2){ref-type="fig"}) and cell cycle profiles ([Fig. 2f](#F2){ref-type="fig"}) similar to Usp16^+/+^ ESCs. This contrasts with studies in HeLa cells, where USP16 deletion causes a slow growth phenotype, partially due to the defects of H2A deubiquitination during cell cycle G2/M phase progression^[@R26],[@R41]^. Usp16^−/−^ ESCs stained positively for alkaline phosphatase ([Fig. 2b](#F2){ref-type="fig"}). Pluripotent genes Oct4, Sox2, and Nanog and PRC subunits Ring1B, Suz12, and Ezh2) were not affected by Usp16 deletion ([Fig. 2d](#F2){ref-type="fig"}). Together, these studies demonstrate that Usp16 regulates ubH2A levels in ESCs, and is not required for ESC viability and identity.

Usp16 binding with relation to gene expression and ubH2A level {#S5}
--------------------------------------------------------------

Since Usp16 regulates ubH2A levels in ESCs, and PRC1 and H2A ubiquitination are enriched at developmental and metabolic genes in ESCs^[@R15],[@R19]^, we investigated whether Usp16 regulates gene expression in ESCs by RNA-sequencing (RNA-seq). Usp16 knockout was associated with an apparent decrease of transcript abundance ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}), consistent with the role of Usp16 as a histone H2A deubiquitinase functioning in gene activation. 1,094 genes were significantly differentially expressed (Log~2~\[Fold change\] \>2 cutoff), with 330 genes up-regulated and 764 genes down-regulated in Usp16^−/−^ ESCs ([Fig. 3a](#F3){ref-type="fig"}). Up-regulated genes are particularly enriched for myofibril assembly, macromolecular complex assembly, chromatin assembly, and nucleosome organization, while down-regulated genes are enriched for transcription regulation, RNA, nitrogen, macromolecule metabolism ([Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}), indicating that further increasing ubH2A levels by inactivation of Usp16 affects many basic cellular processes However, removing ubH2A by knocking out Ring1A/1B and further increasing ubH2A by inactivation of USP16 primarily affect distinct groups of genes, only 12.6% of Usp16 knockout affected genes (1,094, including both up- and down- regulated, [Fig. 3a](#F3){ref-type="fig"}) overlaps with genes affected by Ring1A/B inactivation (1,156, including both up- and down- regulated)^[@R18]^ ([Supplementary Fig. 2d](#SD1){ref-type="supplementary-material"}). Since Usp16 knockout ESCs maintain ESC identity, the deregulation of these genes does not appear to impede ESC self-renewal. However, USP16^−/−^ ESCs do have a higher tendency for differentiation under certain culture conditions compared to USP16^+/+^ ES cells ([Supplementary Fig. 2e](#SD1){ref-type="supplementary-material"}), indicating that USP16-regualted gene expression also contributes to the stabilization of the pluripotent gene expression program. We further validated the RNA-seq results by real-time PCR of ten randomly selected genes ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}). These results confirmed our RNA-seq data and revealed that Usp16 regulates gene expression in ESCs.

To determine whether Usp16 regulates H2A ubiquitination level at PRC1 target genes in ESCs, we first determined the Usp16 binding profile in ESCs by ChIP sequencing (ChIP-seq). ChIP-sequencing results revealed that USP16 binds to all chromosomes with no particular bias for any individual chromosomes ([Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}). Tag counts normalized to the coverage of different gene structures revealed that USP16 binding is particularly enriched in the proximal regions (2kb upstream) of transcription start site (TSS) and 5′UTR with relatively low strength in 5′distal regions (50 kb upstream of TSS), gene coding regions (both exons and introns), 3′UTR, 2 kb downstream of TTS, 3′distal region (50 kb), and non-genic regions compared to IgG ([Supplementary Fig. 3b](#SD1){ref-type="supplementary-material"}). To gain insight into the role of Usp16 in gene regulation, we performed a meta-gene analysis combining all genes in the mouse genome, including up and downstream regions. This analysis revealed that USP16 specifically binds to gene promoter regions, defined as -2 kb to −1 kb of TSS sites ([Fig. 3b](#F3){ref-type="fig"}). Parallel ChIP-seq experiments with Usp16 antibody in Usp16^−/−^ ESCs did not reveal any significant binding ([Supplementary Fig. 3c](#SD1){ref-type="supplementary-material"}), indicating the specificity of ChIP-seq signals. To better understand the significance of Usp16 binding, we employed peak calling analysis (see *methods*) and identified \~7,000 Usp16 binding sites, which occupy 4,814 promoters. Usp16 bound genes are enriched for genes encoding proteins involved in RNA processing, RNA binding, protein localization, macromolecule catabolic process, protein transport, DNA binding, cell cycle, chromosome organization, protein biosynthesis, DNA repair, RNA polymerase activity, and proteasome complex, indicating a potential and wide-spread function of Usp16 in regulating a variety of fundamental cellular processes, although only limited amounts of genes show significant changes when Usp16 is inactivated ([Supplementary Fig. 3d](#SD1){ref-type="supplementary-material"}).

To determine the site-specific effects of Usp16 on H2A ubiquitination, we measured ubH2A levels in Usp16^+/+^ and Usp16^−/−^ ESCs by native ChIP-seq. Consistent with recent studies, ubH2A was enriched at gene promoters ([Fig. 3c](#F3){ref-type="fig"})^[@R19],[@R21]^. By using peak calling analysis, we identified 2,433 gene promoters significantly enriched for ubH2A. These genes strongly overlap with ubH2A enriched genes reported in a recent study (75 % overlapping, similar binding profiles, and similar GO categories, [Supplementary Fig. 3e](#SD1){ref-type="supplementary-material"})^[@R19]^, indicating the reliability of our native ChIP-seq experiments. Genes bound by ubH2A are mainly developmental and transcription regulators ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). 2,022 genes become newly enriched for ubH2A in Usp16^−/−^ ESCs, indicating a significant role for Usp16 in regulating ubH2A levels at these genes ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). These genes include some developmental regulators but are mainly enriched for general biological processes, consistent with recent report^[@R19]^ ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). Supporting our biochemical assays, Usp16 knockout caused a significant increase of ubH2A levels without any apparent effects on H2A levels ([Fig. 3c](#F3){ref-type="fig"}). To better define the relationships between Usp16, ubH2A level, PRC1 and gene expression on a gene by gene basis we generated binding profile heat maps. Genes were sorted based on expression level ([Fig. 3d](#F3){ref-type="fig"}, the 1,000 highest and least expressed genes are shown). Since the bottom genes are largely unexpressed (FPKM\<1), we re-sorted these genes using Ring1B binding extracted from a recent publication^[@R42]^. The heatmaps of Usp16 binding reinforces the metagene analysis, illustrating localization specific to the promoter regions of virtually all genes ([Fig. 3d](#F3){ref-type="fig"}). Furthermore, consistent with a role in promoting transcriptional activity, Usp16 was more highly enriched at active promoters than silent genes ([Fig. 3d](#F3){ref-type="fig"}). Ring1B localization was also specific to the promoter regions of virtually all genes, but its binding was more prominent among the silent genes than in the most highly expressed ([Fig. 3d](#F3){ref-type="fig"}). Consistent with each protein's enzymatic activity, ubH2A was virtually undetectable at active genes (where Usp16 was most abundant), and accumulated among silent genes (where Ring1B was most abundant) ([Fig. 3d](#F3){ref-type="fig"}). Furthermore, the heatmaps clearly illustrate the strong correlation between the presence of Ring1B and that of ubH2A, as previously reported^[@R15],[@R19],[@R21]^. Both the heatmap and metagene analysis illustrate that ubH2A levels are markedly increased in Usp16^−/−^ ESCs ([Fig. 3d](#F3){ref-type="fig"}, [3e](#F3){ref-type="fig"}, [3f](#F3){ref-type="fig"}, [Supplementary Fig. 4c](#SD1){ref-type="supplementary-material"}). Visualization of H2A signal did not reveal changes in H2A signal in Usp16^+/+^ or Usp16^−/−^ ESCs ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}), indicating the specificity of the detected ubH2A changes. Further evidence that Usp16 and Ring1B competitively regulate ubH2A levels was provided by conventional ChIP-qPCR assay. As shown in [Supplementary Fig. 4d](#SD1){ref-type="supplementary-material"}, overexpression of Ring1B and Usp16 increased the levels of these proteins at gene promoters. Importantly, overexpression of Ring1B correlates with an increase of ubH2A and overexpression of Usp16 correlates with a decrease of ubH2A at gene promoters ([Supplementary Fig. 4d](#SD1){ref-type="supplementary-material"}). Consistent with a role of ubH2A in gene repression, ubH2A enriched genes have decreased expression in response to Usp16 knockout ([Fig. 3g](#F3){ref-type="fig"}). In summary, these data reveal that Usp16 binds to gene promoter, positively correlates with gene expression, and inversely correlates with Ring1B binding and H2A ubiquitination levels.

Usp16^−/−^ ESCs are defective for differentiation {#S6}
-------------------------------------------------

Although Usp16 is not required for ESC identity, Usp16 knockout is lethal during early embryogenesis in mice, suggesting that Usp16 knockout may affect ESC differentiation. To determine whether Usp16 regulates ESC differentiation, we differentiated Usp16^−/−^ and Usp16^+/+^ ESCs by forming embryoid bodies (EBs) and compared their phenotypes. The number of EBs formed from Usp16^−/−^ ESCs (Usp16^−/−^ EBs) is similar to the number of Usp16^+/+^ ESC derived EBs (Usp16^+/+^ EBs), indicating that Usp16 knockout does not affect EB formation ([Supplementary Fig. 4e](#SD1){ref-type="supplementary-material"} data not shown). The morphology of Usp16^+/+^ EBs was heterogeneous and contained multiple condensed regions refractory to light ([Fig. 4a](#F4){ref-type="fig"}). In contrast, Usp16^−/−^ EBs were more homogeneous, containing fewer light refractory regions and a smaller condensed central region ([Fig. 4a](#F4){ref-type="fig"}). The transparency difference indicates that, even though both ESCs can form EBs, the internal structure of Usp16^−/−^ and Usp16^+/+^ EBs differ. In addition, Usp16^−/−^ EBs exhibited a distinct growth curve ([Fig. 4b](#F4){ref-type="fig"}). Usp16^+/+^ EBs grew rapidly, showing a dramatic increase in diameter between day 3 to day 7 before reaching a plateau between day 7--8. In contrast, Usp16^−/−^ EBs grew more slowly, did not exhibit staged growth, and had not reached maximal growth by the end of the experiment (day 9--12). To better identify the differences between these EBs, we sectioned day 12 EBs and analyzed them by hematoxylin and eosin staining. As shown in [Fig. 4c](#F4){ref-type="fig"}, Usp16^+/+^ EBs exhibited heterogeneous staining and showed different germ layer morphology, such as small cavity structures. In contrast, Usp16^−/−^ EBs stained more homogenously and contained undifferentiated cell clumps, with central regions of dead and apoptotic cells ([Fig. 4c](#F4){ref-type="fig"}). These studies reveal that Usp16^−/−^ ESCs are unable to undergo normal differentiation.

To determine whether the defects in Usp16^−/−^ ESC differentiation are linked to H2A ubiquitination, we analyzed the levels of ubH2A, Usp16, and pluripotent gene markers during EB formation. Usp16 expression exhibits a dynamic change during EB formation, increasing at early stages of ESC differentiation, peaking at day 3--6, and then decreasing to ESC levels after day 6 ([Fig. 4d](#F4){ref-type="fig"}). ubH2A levels during EB formation were largely inversely correlated with Usp16 levels and decreased during the initial stage of EB formation before gradually returning to the levels in ESCs ([Fig. 4d](#F4){ref-type="fig"}, the intensity of ubH2A was measured and labeled). In contrast, Usp16^−/−^ EBs did not exhibit the same dynamic change of ubH2A levels ([Fig. 4d](#F4){ref-type="fig"}). Moreover, while pluripotent genes Oct4, Nanog and Sox2 were quickly repressed in Usp16^+/+^ EBs, becoming undetectable after day 6 ([Fig. 4d](#F4){ref-type="fig"}), these genes remained at high levels in day 12 Usp16^−/−^ EBs ([Fig. 4d](#F4){ref-type="fig"}). To further confirm the western blot results, we measured the RNA levels of pluripotent genes as well as markers for the three primary germ layers in day6 and day12 EBs by RT-qPCR assay. Consistent with the western blot results, the expression of Usp16 in Usp16^+/+^ EBs at day 6 is higher than both day 0 and day 12. There is no detectable expression of pluripotent genes Oct4, Nanog, and Sox2 at day 12 ([Fig. 4e](#F4){ref-type="fig"}), but lineage-specific markers for ectoderm (Vimentin, Nestin, Igf2), mesoderm (Mef2c, Pax3, MyoD), and endoderm (Gata4, Gata6 and FoxA2) are expressed at high levels ([Fig. 4f](#F4){ref-type="fig"}). In contrast, Usp16^−/−^ EBs did not express these lineage-specific markers and maintained high expression levels of pluripotent genes even at day 12 ([Fig. 4e](#F4){ref-type="fig"} and [4f](#F4){ref-type="fig"}). Taken together, these data reveal that Usp16 is required to activate cell type-specific gene expression programs and repress the expression of pluripotent markers during ESC differentiation.

Usp16 is required for removing ubH2A mark during ESC differentiation {#S7}
--------------------------------------------------------------------

PcG proteins regulate gene repression, at least in part, through covalent modification of histones^[@R7],[@R12]^. During cell fate transitions, the repressive chromatin marks H3K27me and ubH2A are selectively resolved at bivalent genes to specify new, lineage specific gene expression profiles. Our studies on EBs formed from Usp16^−/−^ ESCs suggest an intriguing working model wherein Usp16-mediated H2A deubiquitination relieves ubH2A-mediated repression to activate genes required for proper cell lineage commitment. Our studies revealed that Usp16^−/−^ ESCs fail to activate germ layer markers when stimulated to differentiate ([Fig. 4f](#F4){ref-type="fig"}). To determine the effects of Usp16 deletion on gene expression during differentiation, we performed RNA-seq on day 12 EBs. In contrast to the relatively small numbers of differentially expressed genes in Usp16 ^−/−^ ESCs, 2,371 genes exhibited significant changes (Log~2~\[Fold change\] \>2), with 785 genes up-regulated and 1,586 genes down-regulated ([Fig. 5a](#F5){ref-type="fig"}). Gene ontology analysis revealed that the majority of down-regulated genes are involved in development ([Supplementary Fig. 5a](#SD1){ref-type="supplementary-material"}). Genes up-regulated are mainly related to metabolism, biosynthesis or early stage developmental processes such as mesoderm development, or blastocyst development ([Supplementary Fig. 5b](#SD1){ref-type="supplementary-material"}). This indicates that Usp16 is required for the normal ESC differentiation process. By comparing the gene expression profiles of Usp16^+/+^ ESCs and EBs, we identified approximately 1,200 genes up-regulated ([Fig. 5b](#F5){ref-type="fig"}) and 700 genes down-regulated during normal ESC differentiation ([Fig. 5b](#F5){ref-type="fig"}). These differentially expressed genes reflect the normal reprogramming of the gene expression profile during ESC differentiation. Interestingly, the majority of these genes are misregulated during in vitro differentiation of Usp16^−/−^ ESCs into EBs ([Fig. 5b](#F5){ref-type="fig"}, red dots). Thus, Usp16 is required for the proper regulation of gene expression during ESC differentiation.

Since severe defects in differentiation were observed in Usp16^−/−^ EBs, we investigated how Usp16 regulates ESC differentiation by measuring Usp16 binding in Usp16^+/+^ EBs and comparing it to the Usp16 binding profile in Usp16^+/+^ ESCs. Usp16 binding in both EBs and ESCs is significantly enriched at promoter regions ([Fig. 5c](#F5){ref-type="fig"}, compare to [Fig. 3b](#F3){ref-type="fig"}). Parallel experiments in Usp16^−/−^ EBs did not detect any significant Usp16 binding ([Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}), confirming the specificity of the ChIP-seq results. About 40% of Usp16 bound promoters in EBs overlap with promoters bound by Usp16 in ESCs ([Supplementary Fig. 5e](#SD1){ref-type="supplementary-material"}). Interestingly, 4,481 genes, which were not bound by Usp16 in ESCs were bound by Usp16 in EBs ([Supplementary Fig. 5e](#SD1){ref-type="supplementary-material"}). These newly bound genes are enriched for transcription regulation, embryonic development, various developmental processes, regulation of biosynthetic process, and regulation of macromolecule biosynthetic process ([Supplementary Fig. 5f](#SD1){ref-type="supplementary-material"}). These data indicate that Usp16 might be dynamically recruited to novel targets to regulate ubH2A levels and gene expression during ESC differentiation. Importantly, many of these genes are activated during ESC differentiation. To determine the importance of ubH2A in ESC differentiation, we performed ChIP-seq analysis of ubH2A in Usp16^+/+^ and Usp16^−/−^ EBs. Consistent with the western blot results, we found that ubH2A levels at transcription start sites are significantly increased in Usp16^−/−^ EBs compared to Usp16^+/+^ EBs ([Fig. 5d](#F5){ref-type="fig"}). Interestingly, only 57 transcription start sites are significantly enriched for ubH2A in Usp16^+/+^ EBs, while 3,100 transcription start sites are enriched for ubH2A in Usp16^−/−^ EBs ([Fig. 5d](#F5){ref-type="fig"}). This demonstrates that Usp16 is required for global H2A deubiquitination during ESC differentiation. The low levels of ubH2A in Usp16^+/+^ EBs may indicate that cells in EBs are actively undergoing cell fate transition and, therefore, not many genes are repressed. Parallel experiments with H2A antibody reveal the specificity of the ubH2A ChIP-seq ([Supplementary Fig. 5d](#SD1){ref-type="supplementary-material"}). During ESCs differentiation, ubH2A marks were largely removed ([Fig. 5e](#F5){ref-type="fig"}, genes were sorted based on ubH2A level in Usp16^+/+^ ESCs). Deubiquitination of ubH2A is strongly linked to Usp16 binding ([Fig. 5e](#F5){ref-type="fig"}). Importantly, Usp16 bound genes remain enriched for ubH2A in Usp16^−/−^ EBs ([Fig. 5e](#F5){ref-type="fig"}).

Direct comparison of Usp16 binding within these genes revealed that there is a clear increase of Usp16 binding in EBs as compared to ESCs ([Fig. 5e](#F5){ref-type="fig"}; qualified in [Fig. 5f](#F5){ref-type="fig"}). The aberrant enrichment of ubH2A in Usp16^−/−^ EBs correlated with decreased expression of these genes as compared to Usp16^+/+^ EBs ([Fig. 5g](#F5){ref-type="fig"}). These data suggest that Usp16 is required to remove the ubH2A repressive marks at developmental genes during ESC differentiation. To confirm our ChIP-seq results, we performed conventional ChIP. As shown in [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}, Usp16 binding to promoter regions of Tbx3, HoxD11, and Gsn genes, which are activated during Usp16^+/+^ ESC differentiation, were significantly reduced in Usp16^−/−^ EBs as compared to Usp16^+/+^ EBs. Importantly, the absence of Usp16 binding in Usp16^−/−^ EBs correlated with increased ubH2A levels at promoter regions. These results suggest that Usp16 is required to resolve the ubH2A repressive marks at developmental genes during ESC differentiation.

The primary cause for the differentiation defect of Usp16^−/−^ ESCs {#S8}
-------------------------------------------------------------------

Our studies reveal that Usp16^−/−^ ESCs do not activate lineage-specific genes and repress pluripotency genes when induced to differentiate ([Figs. 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). To determine the primary cause for the undifferentiated phenotype of Usp16^−/−^ EBs, we tested whether knockdown of pluripotent genes or overexpression of lineage-specific genes could rescue this phenotype. Since EB formation requires prolonged culture and selection of infected cells caused substantial cell death during EB formation , we tested whether the undifferentiated phenotype of Usp16^−/−^ ESCs could be recapitulated in other culturing systems. For this purpose, we cultured control and Usp16^−/−^ ESCs in gelatin-coated plates without LIF to induce ESC differentiation. As shown in [Fig. 6a](#F6){ref-type="fig"} and [6b](#F6){ref-type="fig"}, when cultured for 6 to 8 days, control Usp16^+/+^ ESCs successfully differentiated, as evidenced by the repression of pluripotent genes Oct4 and Nanog, and activation of lineage-specific genes including Gata4, Gata6, Hoxc6 (control Usp16^+/+^). In this culture system, Usp16^−/−^ ESCs also failed to differentiate, as evidenced by the high expression of Oct4 and Nanog, and low levels of expression of differentiation-associated genes including Gata4, Gata6, Hoxc6, etc. ([Fig. 6a](#F6){ref-type="fig"} and [6b](#F6){ref-type="fig"}). We next tested whether knockdown of Oct4 could rescue the undifferentiated phenotypes. As shown in [Fig. 6a](#F6){ref-type="fig"}, when Oct4 was significantly knocked down in Usp16^−/−^ ESCs, Nanog remains highly expressed and lineage-associated genes Gata4, Gata6, Igfbf5 and Hoxc6 remains silenced in these cells (compare Usp16^+/+^ and Usp16^−/−^ with Oct4 KD). These data indicate that the failure to repress pluripotent gene expression is unlikely the primary cause for the undifferentiated phenotype of Usp16^−/−^ ESCs.

To determine whether the failure to activate lineage-specific gene expression is the primary cause for the undifferentiated phenotype of Usp16^−/−^ ESCs, we tested whether the ectopic over-expression of Usp16-target genes, which overcome the repressive ubH2A chromatin marks in Usp16^−/−^ ESCs, could rescue the undifferentiated phenotype. For this purpose, we expressed Usp16 target gene, HoxB4, in control wild type Usp16^+/+^ and Usp16^−/−^ ESCs by lentiviral infection. As shown in [Fig. 6b](#F6){ref-type="fig"}, HoxB4 is highly expressed in differentiated Usp16^+/+^ and Usp16^−/−^ ESCs when compared to the uninfected ESCs. Although the expression level of HoxB4 in Usp16^−/−^ ESCs is slightly lower than in Usp16^+/+^ ESCs, pluripotent gene Oct4 was significantly repressed ([Fig. 6b](#F6){ref-type="fig"}) and differentiation-associated genes Gata4, Gata6, Runx1, and Gata2 were significantly activated in HoxB4-infected Usp16^−/−^ ESCs ([Fig. 6b](#F6){ref-type="fig"}). These data suggest that the inability to activate lineage-specific gene expression, but not the failure to repress pluripotent genes, is the primary cause for the undifferentiated phenotype of Usp16^−/−^ EBs.

Wild-type Usp16 rescues Usp16^−/−^ ESC differentiation defect {#S9}
-------------------------------------------------------------

To determine whether defects in Usp16^−/−^ EB differentiation are due to Usp16 deubiquitinase activity, we electroporated wild type and catalytically inactive Usp16 targeting vectors into Usp16^−/−^ ESCs. As shown in [Fig. 7a](#F7){ref-type="fig"}, wild-type and mutant Usp16 were expressed at levels similar to that in Usp16^+/−^ ESCs. Expression of wild-type but not enzymatically inactive mutant Usp16 decreased the ubH2A level in Usp16^−/−^ ESCs ([Fig. 7a](#F7){ref-type="fig"}). When these ESCs were used for EB formation, we found that a significant number of EBs formed from Usp16^−/−^ ESCs rescued with wild-type Usp16 displayed a differentiated phenotype ([Fig. 7b](#F7){ref-type="fig"}, see insertion for relative ratio of differentiated EBs) while virtually all EBs formed from ESCs rescued by catalytically inactive Usp16 exhibited an undifferentiated phenotype ([Fig. 7b](#F7){ref-type="fig"}). The differentiated phenotype was further confirmed by RT-qPCR analysis of lineage-specific genes in these EBs. As shown in [Fig. 7c](#F7){ref-type="fig"}, expression of the Igf2, Vimentin, Gata4, Gata6, and Foxa2 genes was significantly increased in EBs formed from Usp16^−/−^ ESCs rescued by wild-type Usp16. Surprisingly, although there was a modest reduction in the expression of pluripotent genes Oct4 and Nanog, we did not observe a difference between EBs rescued by wild-type or catalytically inactive mutant Usp16 ([Fig. 7c](#F7){ref-type="fig"}). This is likely due to the presence of both undifferentiated and differentiated EB populations derived from Usp16^−/−^ ESCs rescued by wild-type Usp16 ([Fig. 7b](#F7){ref-type="fig"}, see insertion for relative ratio of differentiated EB).

Based on these studies, we propose a model for Usp16 in regulating ESC gene expression and differentiation ([Fig. 7d](#F7){ref-type="fig"}). In ESCs, Usp16 binds to a large number of genes involved in RNA-processing, metabolic process, chromosome organization. The binding of Usp16 is positively correlated with gene expression levels and inversely correlated with ubH2A levels and Ring1B binding. When ESCs are differentiated, Usp16 is required to reverse ubH2A mediated gene repression and enables gene activation and subsequent ESC differentiation. When Usp16 is absent, the uH2A repressive marks persist at developmental regulators and ESCs do not differentiate.

Discussion {#S10}
==========

ESCs are valuable resources for regenerative medicine and powerful tools for studying mammalian development. Understanding the molecular mechanisms controlling ESC pluripotency and lineage specification is a prerequisite for its medical application. Epigenetic mechanism plays important roles in establishing and maintaining cell type-specific gene expression program^[@R2]--[@R4]^. Previous studies have revealed critical roles for PRC2 and RC1 in repression of lineage-specific gene expression programs and stabilizing pluripotent gene expression programs in ESCs^[@R3],[@R5],[@R6]^. Previous studies from our laboratory and others reveal that USP16 functions as a histone H2A deubiquitinase to regulate gene expression at specific genes or loci^[@R26],[@R43]^. However, the genome binding profile of Usp16 and the genes regulated by Usp16 at a genome scale were not revealed in these studies. Recent studies also reveal that in Down's syndrome, where Usp16 is triplicated, Usp16 may contribute to somatic stem cell defects^[@R31]^. Usp16 has also been shown to coordinate with Aurora B-mediated H3S28 phosphorylation to ensure gene transcription in quiescent lymphocytic cells^[@R32]^. Understanding the molecular mechanism of Usp16 is necessary for understanding the function of Usp16 in these processes. In this study, we demonstrated that Usp16 regulates ubH2A levels and gene expression in ESCs. Our data reveal that Usp16 binds to a large number of genes in ESCs, and Usp16 binding is inversely correlated with ubH2A levels and Ring1B binding, and positively correlated with gene expression levels. Usp16 knockout results in a significant increase of ubH2A levels, correlating with a decrease of gene expression. Although Usp16 is not required for ESC viability and self-renewal, Usp16 knockout ESCs have altered gene expression pattern and are not stable at certain culture conditions. Therefore, this study identifies Usp16 and H2A deubiquitination as critical regulators for gene expression to stabilize pluripotent gene expression program in ESCs. This study adds Usp16 and H2A deubiquitination to the long list of factors regulating ESC function.

More significantly, our studies revealed that Usp16 and H2A deubiquitination are required for ESC lineage commitment or differentiation. Usp16 knockout ESCs fail to differentiate. Intriguingly, the failure to activate developmental regulators is the primary cause for the undifferentiated phenotype of Usp16^−/−^ ESCs. The failure to activate lineage specific gene expression could be attributed to the inability of Usp16^−/−^ ESCs to remove repressive ubH2A marks from developmental regulators ([Figs. 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). This result highlights the opposing regulatory roles of Usp16-mediated ubH2A deubiquitination to PRC1-mediated ubH2A. Therefore, these studies identify Usp16 and H2A deubiquitination as previously uncharacterized epigenetic mechanisms, which function independently of H3K27me and H3K4me, to control ESC lineage commitment. This study not only provides further evidence for ubH2A in gene silencing^[@R20],[@R21]^ but also a more comprehensive understanding of the functions of H2A ubiquitination in chromatin and cellular regulation.

Methods {#S11}
=======

Cell culture {#S12}
------------

Mouse V6.5 (129 × B6 F1 hybrid) ESCs used for gene targeting and C57BL/6J mice for germline transmission are from Dr. Tim Townes (University of Alabama at Birmingham). CAGG-Cre mice are from Dr. Bradley Yoder (UAB). All derived ESCs were cultured in ESC media, containing DMEM medium (High glucose, Gibco MT-10-013) supplemented with 50unit/ml penicillin and streptomycin (Life technologies, 15070-063), 18% murine ESC defined FBS (Thermo Scientific, SH30070.03E), 2mM L-glutamine (Cellgro, 25-005-CI), 1mM sodium pyruvate (Gibco, 11360-070), 1X nonessential amino acids (Cellgro, 25-025-CI, 100X stock), 1X nucleoside (Millipore, ES-008-D, 100X stock), 0.007% β-mercaptoethanol (Fisher, O3446I), and 1000unit/ml mLIF (Millipore, ESGRO) on irradiated mouse embryonic fibroblasts (Millipore, PMEF-NL) and passaged every other days as described previously^[@R16]^. For induction of Cre recombinase, Usp16^2lox:2lox^:CAGG Cre ESCs were cultured in medium containing 1μM 4-hydroxytamoxifen (Sigma, H7904) for 3--5 days and then on ESC culture medium.

Generation of Usp16 knockout and conditional knockout mice {#S13}
----------------------------------------------------------

To generate Usp16 knockout and conditional knockout mice, targeting vectors were constructed using sib selection and recombineering technology in DY380 bacteria stain with neomycin selection^[@R44]^. Targeting vectors were then electroporated into V6.5 ESCs. After genotyping and sequencing to confirm the correctly recombined knockout allele, Usp16^+/−^ or Usp16^2lox/+^ ESCs were injected into C57BL/6 blastocysts to clone mice. The chimeric mice were backcrossed with C57BL/6 and Usp16^+/−^ mice were intercrossed for ESC derivation or embryo characterization. Usp16^2lox/+^ mice were crossed with CAGG-Cre transgenic mice to obtain Usp16^2lox/+^: CAGG-Cre mice, which was intercrossed or crossed with Usp16^2lox:2lox^ mice for ESC derivation. Primers used for genotypes are labeled in [Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}. Primer sequences are included in [Supplemental Table 1](#SD1){ref-type="supplementary-material"}. All animal experiments were carried out according to the guidelines for the care and use of laboratory animals of the University of Alabama at Birmingham Institutional Animal Care and Use Committee (IACUC).

Derivation and characterization of ESCs {#S14}
---------------------------------------

Blastocysts were flushed out from the uterus of Usp16^+/−^ or Usp16^2lox/+^:CAGG-Cre E3.5 female mice with a 27.5 gauge needle connected to 1 ml syringe filled with 1 ml 2i medium^[@R45]^. Blastocysts were then transferred to feeder cell plates with 200 μl sterile tip and cultured with 2i medium^[@R46]^ or regular ESC medium for 5--8 days. ESC-like colonies formed from ICM outgrowths were handpicked using sterile pipette tips and dissociated by 0.25% trypsin and expanded in ESC medium. For proliferation rate assay, 1 × 10^4^ ESCs were seeded in 12 well plates and cell numbers were counted and the same seeding procedure was repeated every other day. Western blot assay and qPCR were performed using standard protocol included in the method section^[@R47]^. Antibodies include anti-Usp16 (1:1000)^[@R26]^, anti-ubH2A (Millipore, 05-678, 1:1000), anti-ubH2B (Millipore, 05-1312, 1:1000), anti-H3 (Abcam, ab100938, 1:5000), anti-GAPDH (Sigma, G9545, 1:5000), Anti-Nanog (R&D Systems, AF2729, 1: 2000), Anti-Oct4 (Santa Cruz Biotechnology, SC9081, 1:2000), and anti-Sox2 (Cell signaling, 3579, 1:2000). Alkaline phosphatase substrate kit was from Vector laboratory (SK-5100).

Cell cycle analysis {#S15}
-------------------

2 × 10^6^ control wild type or Usp16^−/−^ ESCs were trypsinized and washed with PBS once. Cell pellets were re-suspended in 50μl PBS and 500μl 0.9% NaCl solution was added to each sample with gentle vortex. 1.5ml 95% ethanol was then added to the cell suspension with vortex. Cells were fixed at 4°C for overnight. After fixation, cells were re-suspended in 300μl PBS with 1mg/ml RNAse (Sigma, R-4875) and incubated at 37°C for 20 minutes. 300μl 40μg/ml propidium iodide (Sigma, P1470) was then added to cell suspension for at least 20 minutes before proceeding to FACS analysis.

Embroid body formation and analysis {#S16}
-----------------------------------

Embryoid bodies (EBs) were formed in EB medium (ESC medium without mLIF) in hanging drops (800 cells per 20μl drop) on petri dish lids for 48 hours. EBs were then collected and cultured on a horizontal rotator at 40 rpm in petri dishes and collected at indicated time points. Medium was changed every other day. For each time point, the diameter of 50 EBs was counted. For H&E staining, EBs were fixed in 4% paraformaldehyde in PBS for 4 hours and then in 70% ethanol (overnight), 80% ethanol (1 hour), 90% ethanol (1 hour), 95% ethanol (overnight), 100% ethanol (1 hour, twice), followed by standard H&E staining protocol^[@R47]^. Briefly, sample slides were incubated with Xylene (5 seconds, 10 dips), Secondary Xylene (5 second, 10 dips), 100% ethanol (10 dips), 100% ethanol (3 minutes), 90% ethanol (3 minutes), 70% ethanol (3 minutes), 50% ethanol (3 minutes), distilled water (3 minutes), Mayer's hematoxylin (2 minutes), running distilled water (20 minutes), eosin (30 seconds), 95% ethanol (10 dips), secondary 95% ethanol (10 dips), 100% ethanol (10 dips), 100% ethanol (2 minutes), Xylene (1 minute), Xylene (2 minutes), Xylene (3 minutes). The slides were then covered with cover glass with Permount and dry overnight.

RNA purification and real time PCR assay {#S17}
----------------------------------------

Total RNA was extracted using TRIzol (Life technologies, 15596-026) following the manufacturer's instruction. Isolated RNA was reverse transcribed using M-MLV (Promega, M1701) following the manufacturer's instruction. For quantitative PCR, 0.5 μl cDNA was used as template in a 25 μl reaction containing 1μg oligo dT 15 primers, 0.5 mM dNTPs, RNase inhibitor, M-MLV, and M-MLV buffer. All quantitative PCR reactions were carried out on a Roche LightCycler 480 thermocycler (Roche). Fold change of gene expression levels were calculated according to the 2^−ΔΔ^Ct method as described previously^[@R48]^ and normalized to GAPDH. Primers for real time PCR assay are listed in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

RNA-sequencing and analysis {#S18}
---------------------------

RNA-sequencing was performed on Illumina HiSeq2000 in UAB Heflin Genomic Core Facility. cDNA libraries were constructed with TruSeq library generation kits (Illumina). The cDNA ends were repaired, A-tailed, and adaptor ligated for indexing. The cDNA library was then quantitated by real time PCR in a Roche LightCycler 480 with the Kapa Biosystems kit for library quantitation (Kapa Biosystems) prior to cluster generation. Clusters were then generated to yield approximately 725--825 K clusters/mm^2^ and the density and quality were determined after the first base addition. Paired end 2 × 50bp sequencing runs were performed for all samples. After sequencing, the data was converted to FASTQ Sanger format and then aligned to mouse reference genome mm9 by TopHat^[@R49]^. Cufflinks was used to assemble transcripts, estimate the abundances, and test for differential expression. Cuffmerge was used to compare the assembled transcripts to the reference annotation across multiple experiments. Cuffdiff was then used to determine the change in transcript levels. Cufflinks, Cuffmerge and Cuffdiff analyses were performed as described previously^[@R50]^. Gene ontology analysis was performed using DAVID (<http://david.abcc.ncifcrf.gov/>).

Chromatin immunoprecipitation and ChIP-qPCR assay {#S19}
-------------------------------------------------

ESCs were cultured on feeder cell free plates and fixed with 1% formaldehyde at room temperature for 10 minutes, followed by quenching with 125mM glycine. Cells were collected by scraping and washed with PBS once. EBs was dissociated with 0.25% trypsin (Cellgro, MT-25-053-CI) at 37°C for 10 minutes prior to fixation. About 5 × 10^7^ cells of ESCs and EBs were resuspended in 10ml PBS containing 0.5% Triton X-100 and incubated on ice for 10 minutes. After centrifugation, cell pellets were resuspended in 5ml Tris-EDTA (TE8.0, pH 8.0) containing 0.1% SDS, and protease inhibitors (0.5mM pepstatin A, 1μM leupeptin, 0.5μM aprotinin, 0.5 mM PMSF). Cell suspension was sonicated using the Fisher sonic dismembrator model 500 at 20% output power 20 times for 30 seconds followed by a 30 second rest on ice. After sonication, cell suspension was adjusted with 1× RIPA buffer (10mM Tris-HCl 8.0, 1mM EDTA, 0.1% SDS, 0.1% Na-Deoxycholate and 1% Triton X-100) as described previously^[@R51]^ before immunoprecipitation. About 4--8μg of affinity purified Usp16 antibody and an equal amount of IgG were incubated with 150 μl Protein A agarose beads (50% slurry in PBS) at room temperature for 1.5 hours and then washed with 1 × RIPA buffer twice to remove unbound antibodies. Antibody-protein A complex was then incubated with 5ml sonicated chromatin from 5 × 10^7^ cells in a 15ml canonical tube at 4°C overnight. After incubation, beads were washed in 1.5ml Eppendorf tubes at 4°C with 1ml RIPA buffer (10 minutes, twice), 1ml RIPA buffer with 0.3M NaCl (10 minutes, twice), 1ml LiCl buffer (0.25M LiCl, 0.5% NP40, 0.5% Na-Deoxycholate, 10 minutes, twice), 1ml TE8.0 buffer with 0.2% Triton X-100 (10 minutes, once) and 1ml TE 8.0 buffer (10 minutes, once)^[@R51]^. Beads were then re-suspended in 100μl TE 8.0 buffer and cross-linking was reversed by adding 0.5M NaCl and 1μg/ml RNase A at 65°C overnight. Additional incubation after adding 3--5μl of 10% SDS and 5μl of 20 mg/ml protease K was performed at 55°C for 2 hours to fully dissociate protein-antibody complex. DNA template from ChIP was prepared by standard phenol/chloroform DNA extraction and ethanol precipitation. Eluted DNA was dissolved in 50μl TE 8.0 buffer. For ChIP-qPCR assay, 0.5μl of 1:5 dilution of elution was used as templates in a 20μl reactions using GoTag (Promega, M3001) DNA polymerase as described previously^[@R47]^. Signals were normalized to input DNA. Primers for ChIP-qPCR are included in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

Native chromatin immunoprecipitation {#S20}
------------------------------------

For native ChIP, ESCs and EB (pre-trypsined) were collected and washed with pre-chilled PBS once and incubated in 0.5% NP40 in TBS buffer (10mM Tris-HCl pH 7.5, 3mM CaCl~2~, 2mM MgCl~2~) on ice for 1hour with gentle vortex every 15 minutes. After incubation, cells were homogenized by 10ml Dounce homogenizer and re-suspended in 25% sucrose in TBS. Cells were then transferred to a 15ml tube prefilled with half volume of 50% sucrose in TBS and spun down at 600g for 20minutes. Pellets were washed in 25% sucrose TBS once and re-suspended in nuclear digestion buffer (50mM Tris-HCl pH 7.5, 1mM CaCl~2~, 2mM MgCl~2~, 0.32M sucrose) to reach a rough DNA concentration of 0.5 mg/ml as measured by Nanodrop. 2U/ml micrococcal nuclease (MNase) was added to the chromatin and digestion was carried out at 37°C for 15 minutes and repeated once for the pellet after spinning down the first digestion mixture. Digestion was terminated by addition of 5mM EDTA. Digested chromatin solution was collected and pellet from second digestion was further incubated with nuclear lysis buffer (1mM Tris-HCl pH 7.5, 0.2 EDTA) on ice for 1hour with occasional tapping and then overnight at 4°C with rotation. The supernatant was collected and combined with the digestion supernatants and stored at −80°C. All buffers used were supplemented with protease inhibitors, 5mM PMSF, 5mM NaF, and 2mM Na~3~VO~4~.

For each native ubH2A ChIP, 50μl beads were incubated with anti-IgM bridging antibody (Millipore, 12-488) for 1 hour and washed with 1ml RIPA buffer containing 0.3M NaCl. For H2A ChIP, protein-G agarose bead was washed with 1ml RIPA buffer with 0.3M NaCl. Amount of each antibody used to achieve optimal ChIP performance were determined previously. Briefly, 50μg ubH2A antibody (Millipore, 05-678) and 15μg H2A antibody (Millipore, 07-146) were added to treated protein G agrose beads with 400μg chromatin and incubated at 4°C for overnight. After immunoprecipitation, beads were washed with 1ml RIPA buffer (twice, 10 minutes each), 1ml LiCl buffer (10 minutes, once), and 1ml TE8.0 (10 minutes, once). Washed complex were then eluted from beads with 50mM Tris-HCl pH 8.0, 1mM EDTA, and 1% SDS by incubation at 65°C for 5 minutes and room temperature for 20 minutes with shaking. Elution process was repeated once and eluates were combined and then incubated at 55°C for two hours after addition of 5mM EDTA and 200 μg/ml proteinase K. DNA was isolated by phenol-chloroform extraction and ethanol precipitation and dissolved in TE8.0.

ChIP-Sequencing and analysis {#S21}
----------------------------

ChIP-Sequencing using cross-linked or native chromatin templates was performed at Hudson Alpha Institute Genomic Service Laboratory (GSL) and the National University of Singapore. NEB Next DNA sample prep reagents (New England Biolabs, E6000S/L) were used for end repair, dA-tailing, and adaptor ligation (custom adaptors from Hudson Alpha GSL). The entire volume ligated product was PCR amplified for 15 cycles using Invitrogen's Pfx DNA polymerase using the custom adaptors designed to allow for 96 unique indexes. Size selection was performed on 2% agarose gel. The final library quality was examined by Qubit and Bioanalysis, and real time PCR was performed using KAPA's library quantification kit for Illumina. Each library was diluted to 12.5pM and clustered using a cBot. Each library was sequenced over 1/6th of a HiSeq 2000 lane following standard Illumina protocols for paired end 50bp sequencing.

For data analysis, the converted fastq files obtained from Hudson Alpha GSL were aligned to mouse reference genome mm9 by BOWTIE^[@R49]^. The SAM files after alignment were filtered to remove PCR duplicate and unmapped reads by SAMtools^[@R52]^ on Galaxy before converting to Bed files. After Bed files were generated, these files were subjected to peak calling with MACS on Galaxy using an FDR (False discovery rate) threshold set to ≤ 0.05^[@R53]^. Proximal regions around the transcription start site (−2kb to +1kb) that were occupied by at least one peak were defined as enriched promoters/genes. Coordinates of enriched genes with different binding profiles were then intersected to generate Venn diagrams. To count tag density for all the bed files in the coordinates as indicated in all figures, a 15-step workflow on Galaxy (<http://main.g2.bx.psu.edu/>) was created and available for sharing upon request. To generate heatmaps, individual mm9 gene (RefSeq annotations) was divided into 100 bins using a custom script. Coverage across binned genes plus 10kb upstream of the TSS and 10kb downstream of the TES was generated using BEDTools 'coverageBed' with the -d option^[@R54]^. Outputs were converted to data matrices by a custom script and then visualized as heatmaps in Microsoft Excel 2010 using conditional formatting options. Gene ontology analysis was performed using DAVID (<http://david.abcc.ncifcrf.gov/>).

Usp16 rescue experiment {#S22}
-----------------------

Usp16^−/−^ ESCs were re-targeted using the same targeting vector or a C205S point mutant vector to generate Usp16 conditional knockout ESCs using procedures similar to those described in the mouse generation method section. Usp16 protein level was measured by western blotting to confirm that wild type or C205S Usp16 was expressed at control levels. EB formation, H&E staining, and RT-qPCR assay were performed as described.

Oct4 shRNA and HoxB4 overexpression lentivirus infection {#S23}
--------------------------------------------------------

pLKO-Oc4 shRNA and control vectors were kindly provided by Dr. Rui Zhao (UAB Stem Cell Institute). pDL171-HoxB4 and control vectors were kindly provided by Dr. Chia-Wei Chang (UAB Stem Cell Institute). Lentiviral vectors together with packaging vectors were transfected in to 293T cell using calcium phosphate and virus were collected at 48 hour and 72 hour post-infection and pooled. After titration of individual virus, 5×10^5^ Usp16^−/−^ ESCs were infected by Oct4 shRNA lentivirus or HoxB4 expression vectors on gelatin coated 6 well plates by spinoculation at room temperature for 2 hours and then incubated at 37°C for overnight before switching to ESC medium. After infection, ESCs were further cultured for 5--7 days before collecting for RNA extraction and RT-qPCR assay. Usp16^+/+^ and Usp16^−/−^ECS without infection were used as controls.

Usp16 and Ring1B overexpression retrovirus infection {#S24}
----------------------------------------------------

pMigR1-Usp16 and pMigR1-Ring1B retroviral vectors together with packaging vector were transfected in to 293T cell using calcium phosphate and virus were collected at 48 hour and 72 hour post-infection and pooled. After titration of individual virus, 5×10^5^ Usp16^+/+^ ESCs were infected by Usp16 or Ring1B retrovirus on gelatin coated 6 well plates by spinoculation at room temperature for 2 hours and then incubated at 37°C for overnight before switching to ESC medium. After infection, ESCs were further cultured for 2--3 days before collecting for ChIP-qPCR assay.

Supplementary Material {#S25}
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![Usp16 is required for mouse embryonic development\
**a.** Schematic representation of the strategies used to generate Usp16 knockout mice. Partial regions of Usp16 locus (from exon 2 to exon 7) are shown. Exons are shown as filled boxes and LoxP sites as filled triangles. PCR primers used for genotyping are shown as arrows. Position of cysteine 205, an amino acid essential for Usp16 deubiquitination activity, is indicated.\
**b.** Identification of correctly targeted mouse embryonic stem cells. Top panels, phase contrast of the morphology of correctly targeted Usp16 ESCs as compared to wild type V6.5 ESCs. Bottom panel, images of genotyping results of ESCs as shown in the top panel. PCR reactions were performed using primers as indicated in panel A. Scale car, 50μm.\
**c.** Usp16 is required for mouse viability. Images of PCR genotyping of offspring from Usp16^+/−^ mice intercrossing. The number and ratio of wild type and heterozygote adult mice genotyped were shown (The number in the parenthesis indicates litters examined).\
**d.** Usp16 knockout results in early embryonic lethal. Image and PCR genotyping of E7.5 embryos from Usp16^+/−^ mice intercrossing showing partially re-absorption of Usp16^−/−^ embryos. The number and ratio of embryos genotyped were shown (The number in the parenthesis indicates litters examined).\
**e.** Usp16^−/−^ blastocysts are viable. PCR genotyping of blastocysts from Usp16^+/−^ intercrossing. The number and ratio of blastocysts genotyped were shown under the PCR image (The number in the parenthesis indicates female mice sacrificed)](nihms584323f1){#F1}

![Usp16 knockout does not affect ESC viability and identity\
**a.** Schematic representation of the strategy used to delete Usp16 (top panels) and an image of genotyping result of Usp16 deleted ESCs (bottom panel). PCR primers used for genotyping are indicated in the top panel.\
**b.** Phase contrast images (top panels) and alkaline phosphatase staining images (bottom panels) of Usp16^+/+^ and Usp16^−/−^ ESCs. Scale bar, 50μm.\
**c.** Western blot analysis of Usp16 (top panel), H2A ubiquitination (third panel), and H2B ubiquitination (fifth panel) levels in two independent Usp16^+/+^ and Usp16^−/−^ ESC lines. The quantitation of ubH2A signals was labeled. Signals in control Usp16^+/+^ ESCs were arbitrarily set as 1. GAPDH, histone H2A, H2B, and H3 were used as loading controls.\
**d.** Western blot analysis of the levels of pluripotent genes and PRC subunits in two independent control Usp16^+/+^ and Usp16^−/−^ ESC lines. β-tubulin was used as a loading control.\
**e.** Growth curve of two independent control Usp16^+/+^ and Usp16^−/−^ ESC lines. 1 × 10^4^ ESCs were seeded in 12 well plates and cell numbers were counted every other day. The same seeding procedure was repeated every other day.\
**f.** Fluorescence activated cell sorting (FACS) analysis of control Usp16^+/+^ and Usp16^−/−^ ESC lines. The percentages of cell populations at each cell cycle phase were labeled.](nihms584323f2){#F2}

![Usp16 binds to transcription start site and positively correlates with gene expression and inversely correlates with H2A deubiquitination levels\
**a.** Scatter plot of gene expression levels in Usp16^+/+^ and Usp16^−/−^ ESCs as determined by RNA-seq. The fragments per kilobase of exon model per million mapped reads (FPKM), was calculated for each transcript using Cufflinks and transformed to Log2 (FPKM) as relative RNA level. Genes that are significantly deregulated (Log~2~ \[Fold change\] \> 2) in Usp16^−/−^ ESCs were shown in the bottom table.\
**b.** Binding of Usp16 (red line) and IgG (black line) to gene coding regions plus 10kb upstream of the transcription start site (TSS) and downstream of transcription ending site (TES) in Usp16^+/+^ ESCs. Parallel experiments in Usp16^−/−^ ESCs were shown in [supplementary Fig. 3c](#SD1){ref-type="supplementary-material"}.\
**c.** ubH2A (orange line, Usp16^−/−^; blue line, Usp16^+/+^) and H2A (brown line, Usp16^−/−^; green line, Usp16^+/+^) signals across gene transcribing regions plus 10kb upstream of TSS and downstream of TES.\
**d.** Usp16 (first column), Ring1B (second column), and ubH2A (third and fourth columns) distribution at individual genes in Usp16^+/+^ and Usp16^−/−^ ESCs. Top row, top 1,000 expressed genes sorted by relative expression (FPKM). Bottom row, bottom 1,000 expressed genes in gene list re-sorted based on Ring1B signal. Analyses span 10kb upstream of the TSS, the gene body, and 10kb downstream of the TES.\
**e.** Binding profiles of ubH2A in bottom 1,000 expressed genes re-sorted by Ring1B binding in Usp16^+/+^ and Usp16^−/−^ ESCs.\
**f.** ubH2A distribution at individual genes in Usp16^+/+^ and Usp16^−/−^ ESCs. Genes are sorted based on ubH2A signals in Usp16^+/+^ ESCs.\
**g.** Expression levels of genes in Fig.3f in Usp16^+/+^ and Usp16^−/−^ ESCs. p-value is calculated by the Student's t-test. Top whisker and bar represent 98^th^ percentile of genes. Bottom whisker and bar represent 2^nd^ percentile of genes above zero.](nihms584323f3){#F3}

![Usp16^−/−^ ESCs are defective for differentiation\
**a.** Phase-contrast images of EB morphology during EB formation from Usp16^+/+^ and Usp16^−/−^ ESCs.\
**b.** Growth curve of EBs formed from Usp16^+/+^ and Usp16^−/−^ ESCs. The diameter of EBs at each day was measured and compared. For each time point, 50 EB diameters were measured. Means and standard deviations (error bars) are shown.\
**c.** Hematoxylin and eosin staining of day12 EBs formed from Usp16^+/+^ and Usp16^−/−^ ESCs. Day 12 EBs from Usp16^−/−^ ESCs lack organized structure and failed to differentiate. Scale car, 100μm.\
**d.** Western blot analysis of the levels of Usp16 (top panel), ubH2A (sixth panel), and pluripotent genes (second to fourth panels) during EB formation. ubH2A signals were quantified as in [Fig. 2c](#F2){ref-type="fig"}. Signals in Usp1^6+/+^ EBs at day 0 were arbitrarily set as 1. GAPDH and histone H3 were used as loading controls.\
**e.** Real-time PCR analysis of Usp16 and pluripotent genes expression at day 0, day 6 and day 12 during EB formation of two independent Usp16^+/+^ and Usp16^−/−^ ESC lines. Gene expression levels at day 0 were arbitrary set as 1. Bars represent means + standard deviation (SD). Number of biological replicates n=3.\
**f.** Real-time PCR analysis of lineage-specific genes expression at day 0, day 6 and day 12 during EB formation from two independent Usp16^+/+^ and Usp16^−/−^ ESC lines. Gene expression levels at day 0 were arbitrary set as 1. Bars represent means + SD. Number of biological replicates n=3.](nihms584323f4){#F4}

![Usp16 is required for resolving ubH2A marks during ESC differentiation\
**a.** Scatter plot of gene expression levels in EBs formed by Usp16^+/+^ (black line) and Usp16^−/−^ ESCs (red dots). mRNA expression level was calculated as log~2~ (FPKM). Summary of genes up- or down-regulated in Usp16^−/−^ ESCs was shown in the table.\
**b.** Scatter plot of up- (top panel) and down- (bottom panel) regulated genes during Usp16^+/+^ ESC differentiation (black line) as compared to their expression during Usp16^−/−^ ESC differentiation (red dots). Genes were sorted according to log2 fold change in expression.\
**c.** Binding of Usp16 (red line) and IgG (black line) to gene transcribing regions plus 10kb upstream of TSS and downstream of TES in Usp16^+/+^ EBs. Parallel experiments with Usp16^−/−^ EBs were shown in [supplementary Fig. 5d](#SD1){ref-type="supplementary-material"}.\
**d.** ubH2A signal (orange line, Usp16^−/−^ EBs; blue line, Usp16^+/+^ EBs) and H2A signal (brown line, Usp16^−/−^ EBs; green line, Usp16^+/+^ EBs) across gene transcribing regions plus 10kb upstream of TSS and downstream of TES.\
**e.** ubH2A (first three columns) and Usp16 (fourth and fifth columns) distribution at individual genes in Usp16^+/+^ ESCs, Usp16^+/+^ EBs, and Usp16^−/−^ EBs. Genes were sorted based on ubH2A binding in Usp16^+/+^ ESCs. Top 1,000 expressed genes were shown.\
**f.** Usp16 signal in Usp16^+/+^ ESCs (red line) and EBs (blue line) of genes as shown in Fig. 5e.\
**g.** A box and whisker plot, as described in [Fig. 3a](#F3){ref-type="fig"}, of the relative expression of ubH2A enriched genes in Usp16^+/+^ and USP16^−/−^ EBs. P-values is calculated by the Student's t-test. Top whisker and bar represent 98^th^ percentile of genes. Bottom whisker and bar represent 2^nd^ percentile of genes above zero.](nihms584323f5){#F5}

![The failure to activate lineage specific gene expression is the cause of undifferentiated phenotype of Usp16^−/−^ ESCs\
**a.** Knockdown of Oct4 has no effect on Usp16^−/−^ ESC differentiation. RT-qPCR analysis of genes in differentiated Usp16^+/+^ and Usp16^−/−^ ESCs with or without infection of shRNA against Oct4. Bars shown represent means + SD. Number of biological replicates n=2.\
**b.** Expression of HoxB4 triggers Usp16^−/−^ ESC differentiation. RT-qPCR analysis of genes in differentiated control and Usp16^−/−^ ESCs with or without infection of HoxB4 lentivirus. Bars shown represent means + SD. Number of biological replicates n=2.](nihms584323f6){#F6}

![Usp16 but not the enzymatically inactive mutant rescues the undifferentiated phenotype of Usp16^−/−^ ESCs\
**a.** Western blot analysis of Usp16 (top panel) and H2A ubiquitination levels (third panel) in Usp16^+/−^ ESCs, and Usp16^−/−^ ESCs rescued with wild type or enzymatically inactive C205Smutant Usp16. ubH2A signals were quantified as in [Fig. 2c](#F2){ref-type="fig"}. Signals in Usp16^+/+^ ESCs werearbitrarily set as 1. GAPDH and histone H3 were used as loading controls.\
**b.** Hematoxylin and eosin staining of day12 EBs formed by Usp16^−/−^ ESCs rescued with wild type or enzymatically inactive C205S mutant Usp16. A bar chart summary of EBs exhibiting differentiated phenotype is shown. Scale car, 100μm.\
**c.** RT-qPCR analysis of genes in EBs formed by control, Usp16^+/−^ ESCs, and Usp16^−/−^ ESCs rescued with wild type or enzymatic inactive C205S mutant Usp16. Bars shown represent means + SD. Number of biological replicates n=2.\
**d.** A proposed model for Usp16 and H2A deubiquitination in ESC gene expression and lineage commitment. In ESCs, Usp16 binds to a large number of genes and Usp16 binding inversely correlates with ubH2A levels and positively correlates with gene expression. During ESC differentiation, Usp16 is responsible for reversing H2A ubiquitination at developmental genes, enabling ESC differentiation.](nihms584323f7){#F7}
